Wegovy Cost in 2026: Insurance Coverage, Savings Programs, and Out-of-Pocket Estimates

Written by: (Endocrinologist) | Reviewed by: Dr. John Doe, PharmD | Updated:

The cost of Wegovy® (semaglutide) remains one of the most searched topics in weight management, and for good reason. With a retail list price exceeding $1,300 per month, understanding your real out-of-pocket cost is essential before starting treatment. The good news is that in 2026, there are more ways to save than ever before—from manufacturer savings cards to new oral formulations with lower cash prices.

This comprehensive guide breaks down every pricing scenario you may encounter, whether you have commercial insurance, Medicare, Medicaid, or no insurance at all. We provide verified, up-to-date figures sourced directly from Novo Nordisk, the FDA, and Medicare.gov, so you can make informed financial decisions about your weight management journey.

Medical & Financial Disclaimer

This article is for informational purposes only and does not constitute medical, financial, or insurance advice. Drug prices are estimates based on publicly available data and are subject to change without notice. Your actual cost will depend on your specific insurance plan, pharmacy, and eligibility for savings programs. Always consult with your healthcare provider and insurance company for personalized guidance before making treatment decisions.

Key Takeaways

  • List Price: The retail price of Wegovy® injectable pen is approximately $1,349 per month (~$16,188/year) without any discounts or insurance.
  • With Commercial Insurance: Patients with private insurance can pay as little as $25 per month using the Novo Nordisk Savings Card.
  • Without Insurance (Cash Pay): The NovoCare® Direct program offers Wegovy® for $349 per month, a 74% discount off list price.
  • Medicare Patients: Coverage is limited for weight loss indications, but the Inflation Reduction Act caps Part D out-of-pocket costs at $2,000 per year.
  • New Oral Wegovy® Pill (2026): Cash-pay prices range from $149 to $299 per month depending on dose, offering a more affordable entry point.

Quick Answer: How Much Does Wegovy® Cost?

In 2026, the cost of Wegovy® (semaglutide) varies dramatically based on your insurance status. The manufacturer’s list price for the injectable pen is approximately $1,349 per month. However, most patients do not pay this amount. With commercial insurance and the Wegovy® Savings Card, eligible patients can pay as little as $25 per month. For those without insurance, Novo Nordisk’s NovoCare® Direct cash-pay program brings the cost down to $349 per month. A new oral pill version is also available in 2026, with cash prices starting at $149 per month for the 1.5 mg dose. Low-income, uninsured patients may qualify for the Patient Assistance Program and receive Wegovy® at no cost.

In This Article

Who This Guide Is For

This pricing guide is designed for anyone considering Wegovy® (semaglutide) for chronic weight management and wanting to understand the true cost before starting treatment. Whether you are a patient who has just received a prescription, someone exploring treatment options with your doctor, or a caregiver researching on behalf of a family member, this guide will help you navigate the complex landscape of drug pricing in the United States.

Wegovy® is FDA-approved for chronic weight management in adults with a BMI of 30 kg/m² or greater (obesity), or a BMI of 27 kg/m² or greater (overweight) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia. It is also approved to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight. It is intended to be used alongside a reduced-calorie diet and increased physical activity. [1]

Wegovy® Cost Overview: All Scenarios Compared (2026)

The table below provides a comprehensive comparison of what you can expect to pay for Wegovy® injectable pen across every major pricing scenario in 2026. This is the single most important reference in this article—bookmark it or download our savings guide for future reference.

Wegovy Injectable Pen Cost Comparison by Insurance Status in 2026
Cost Scenario Monthly Cost Annual Cost Who Qualifies
Retail / List Price (no discounts) ~$1,349 ~$16,188 Anyone paying full cash price at a retail pharmacy
Commercial Insurance + Savings Card $25 $300 Patients with private/employer insurance that covers Wegovy®
NovoCare® Direct (Cash Pay) $349 $4,188 Uninsured patients or those whose plan excludes Wegovy®
NovoCare® New Patient Offer $199 (first 2 months) Varies New patients filling 0.25 mg and 0.5 mg doses (through March 31, 2026)
Patient Assistance Program (PAP) $0 $0 Uninsured, low-income patients (income ≤400% FPL)
Medicare Part D (with CV indication) $0–$167 Capped at $2,000 Medicare beneficiaries with qualifying cardiovascular diagnosis
TRICARE (Military) Varies Varies Active duty, retirees, and dependents with valid prescription
GoodRx / Discount Coupons ~$1,000–$1,200 ~$12,000–$14,400 Anyone; modest savings vs. list price (NovoCare® is usually better)

Sources: Novo Nordisk (wegovy.com), Medicare.gov, GoodRx. Prices are estimates current as of February 2026 and subject to change. [2] [3]

With Commercial Insurance: The Wegovy® Savings Card ($25/Month)

If you have private or employer-sponsored health insurance that covers Wegovy®, the Novo Nordisk Savings Card is the single most effective tool to reduce your out-of-pocket cost. This manufacturer-sponsored program can bring your monthly copay down to as little as $25 for a 28-day supply of the injectable pen, or a 30-day supply of the oral pill.

The Savings Card works by covering the difference between your insurance copay and $25, up to a maximum savings of $225 per fill. This means if your insurance copay is $250, you would pay $25 and the card would cover the remaining $225. However, if your copay is already $25 or less, the card provides no additional benefit.

Eligibility Requirements

  • Commercial or private health insurance (employer-sponsored, ACA marketplace, or individual plan) that covers Wegovy®.
  • Not covered by government insurance: Patients with Medicare, Medicaid, TRICARE, or any other federal or state healthcare program are not eligible.
  • Valid prescription for Wegovy® from a licensed U.S. healthcare provider.
  • U.S. resident (including Puerto Rico).

How to Activate

Activating the Savings Card is straightforward. Visit wegovy.com/savings to register online and receive a digital savings card instantly. You can also text SAVE to 83757 to receive your digital card via text message. Present the card at your pharmacy along with your insurance card when filling your prescription. [2]

Without Insurance: NovoCare® Direct Cash-Pay Program ($349/Month)

If you do not have health insurance, or your insurance plan specifically excludes weight management medications, the NovoCare® Direct program is your best option. This Novo Nordisk program provides Wegovy® at a fixed monthly price that represents a 74% discount off the retail list price.

Program Details

  • Monthly cost: $349 per month for the injectable pen (all doses).
  • New patient introductory offer: $199 per month for the first two fills (0.25 mg and 0.5 mg doses) through March 31, 2026. After the introductory period, the price reverts to $349 per month. [2]
  • No insurance required: Open to all U.S. residents with a valid prescription.
  • Home delivery: Medication is shipped directly to your home via NovoCare® Pharmacy (fulfilled by CoAssist Pharmacy).

How to Enroll

You can enroll in NovoCare® Direct by visiting NovoCare.com, calling 1-888-809-3942 (Mon–Fri, 8am–8pm ET), or asking your healthcare provider to enroll you directly through the NovoCare® HCP portal. Once enrolled, your prescription will be filled and shipped to your door.

Patient Assistance Program: Free Wegovy® for Qualifying Patients

Novo Nordisk offers a Patient Assistance Program (PAP) that provides Wegovy® completely free of charge to eligible patients. This is the best option for individuals who are uninsured and have limited income.

Eligibility Criteria

  • U.S. citizen or legal resident.
  • No health insurance (uninsured), or underinsured with no Wegovy® coverage.
  • Household income at or below 400% of the Federal Poverty Level (FPL). For 2026, this is approximately $62,400 for an individual or $129,600 for a family of four.
  • Not eligible for Medicare, Medicaid, or other government-funded programs.
  • Valid prescription from a licensed U.S. healthcare provider.

How to Apply

Download the PAP application from NovoCare.com or call 1-866-310-7549. The application must be completed by both you and your healthcare provider (provider signature required). You will need to submit proof of income (tax return, pay stubs, or signed attestation). Processing time is approximately 2–4 weeks. If approved, you will receive a 90-day supply shipped to your provider’s office. [4]

Medicare Coverage for Wegovy® in 2026

Medicare coverage for Wegovy® is one of the most complex and frequently misunderstood aspects of this medication’s pricing. The key distinction is between the weight loss indication and the cardiovascular risk reduction indication.

What Medicare Covers

In March 2024, the FDA approved Wegovy® to reduce the risk of major adverse cardiovascular events (MACE)—including heart attack, stroke, and cardiovascular death—in adults with established cardiovascular disease and either obesity or overweight. Medicare Part D plans are required to cover at least one GLP-1 agonist for this cardiovascular indication. However, Medicare generally does not cover Wegovy® when prescribed solely for weight loss. [5]

The $2,000 Out-of-Pocket Cap

Thanks to the Inflation Reduction Act (IRA), Medicare Part D beneficiaries now have a $2,000 annual cap on out-of-pocket prescription drug costs. This means that even if Wegovy® is covered but placed on a high-cost tier, your total annual spending on all Part D medications will not exceed $2,000. This is a significant protection for patients on expensive specialty medications. [3]

Action Steps for Medicare Patients

  • Confirm whether your Part D plan covers Wegovy® by checking the plan formulary during Open Enrollment.
  • Ask your provider to submit prior authorization with a cardiovascular diagnosis (ICD-10: I25.x, I63.x, etc.) if applicable.
  • If denied, request a coverage determination and appeal.
  • Consider Medicare Extra Help / Low-Income Subsidy (LIS) if you are income-eligible.

New Oral Wegovy® Pill: Pricing Breakdown (2026)

One of the most significant developments in 2026 is the availability of oral Wegovy® tablets (semaglutide 25 mg). This new formulation offers patients a needle-free alternative and, for cash-pay patients, a potentially more affordable entry point into semaglutide therapy.

Wegovy Oral Pill Pricing by Dose in 2026
Pill Dose Cash Price (Self-Pay) With Insurance + Savings Card Notes
1.5 mg (starting dose) $149/month As low as $25/month 30-day supply; starting dose for titration
4 mg (intermediate dose) $149/month (until April 15, 2026), then $199/month As low as $25/month Introductory pricing available through April 15, 2026
9 mg (maintenance dose) $299/month As low as $25/month 30-day supply; target maintenance dose

Source: Novo Nordisk (wegovy.com). Prices current as of February 2026. [2]

The oral formulation represents a meaningful shift in accessibility. For uninsured patients, the $149–$299 per month cash price is significantly lower than the injectable pen’s $349 per month through NovoCare® Direct, making it a compelling option for those who are cost-sensitive and comfortable with a daily pill rather than a weekly injection.

Additional Cost-Saving Strategies

Beyond the major programs outlined above, there are several additional strategies that can help reduce your Wegovy® costs.

Compare Pharmacy Prices

Prices can vary by hundreds of dollars between pharmacies. Use tools like GoodRx.com or RxSaver.com to compare local prices. Costco pharmacies often offer competitive pricing (no membership required for Rx in most states). Mail-order pharmacies may offer 10–15% savings on 90-day supplies.

Optimize Your Insurance

During Open Enrollment, compare plans specifically for GLP-1 formulary coverage. Request a formulary exception from your insurer with a Letter of Medical Necessity. Ask your employer’s HR department to advocate for plan changes that include weight management coverage.

Explore Nonprofit Assistance

Organizations like NeedyMeds.org, RxAssist.org, and the Patient Advocate Foundation offer free case management and may help connect you with additional assistance programs. State Pharmaceutical Assistance Programs (SPAPs) vary by state and may offer supplemental coverage.

Consider the Oral Pill

If you are paying cash, the new oral Wegovy® pill may offer significant savings over the injectable pen. Discuss with your provider whether the oral formulation is appropriate for your treatment plan. Starting doses begin at just $149 per month.

Download: Wegovy® Savings Guide

Get our free comprehensive savings guide with all programs, eligibility requirements, and a personal savings tracker you can print and use.

Download Free Savings Guide (PDF)

Frequently Asked Questions

Why is Wegovy® so expensive?

Wegovy® is a complex biologic medication that required extensive research, development, and clinical trials to bring to market. The STEP clinical trial program, which demonstrated its efficacy and safety, involved thousands of participants across multiple countries. Manufacturing injectable GLP-1 receptor agonists involves sophisticated biotechnology processes, including recombinant DNA technology and specialized cold-chain logistics. The price also reflects the significant demand for effective, evidence-based weight management therapies.

Does insurance cover Wegovy® for weight loss?

Many commercial insurance plans do cover Wegovy® for chronic weight management, but coverage varies widely. Most plans require prior authorization, which means your doctor must submit documentation proving medical necessity (typically BMI criteria and evidence of weight-related comorbidities). Some plans may also require “step therapy,” meaning you must try and fail a less expensive medication first. Contact your insurance company directly or use the NovoCare® benefits check tool to determine your specific coverage.

Can I use the Savings Card with Medicare or Medicaid?

No. The Wegovy® Savings Card is not available to patients covered by Medicare, Medicaid, TRICARE, or any other federal or state government healthcare program. This is a federal regulation that applies to all manufacturer copay assistance programs. However, Medicare patients may benefit from the $2,000 annual out-of-pocket cap under the Inflation Reduction Act, and low-income patients may qualify for the Patient Assistance Program. [2]

Is it safe to buy Wegovy® from Canada or overseas?

The FDA strongly advises against purchasing prescription medications from foreign pharmacies. While prices may appear lower, there is no guarantee of product authenticity, proper storage conditions, or correct dosing. Counterfeit GLP-1 medications have been identified in international supply chains, posing serious health risks. For the safest and most cost-effective options, use a licensed U.S. pharmacy and explore the domestic savings programs outlined in this guide. [6]

What should I do if my insurance denies coverage?

If your insurance denies coverage for Wegovy®, you have the right to appeal. The appeal process typically involves your doctor submitting a Letter of Medical Necessity along with supporting clinical documentation (BMI history, comorbidities, prior weight loss attempts). Many denials are overturned on appeal, especially when strong clinical evidence is presented. If all appeals are exhausted, consider the NovoCare® Direct cash-pay program ($349/month) or the Patient Assistance Program (free for qualifying patients). For a step-by-step guide, see our Wegovy Prior Authorization & Appeals Guide.

How much does the new Wegovy® pill cost compared to the injection?

The oral Wegovy® pill is available in 2026 at cash-pay prices of $149/month for the 1.5 mg dose, $199/month for the 4 mg dose (after April 15, 2026), and $299/month for the 9 mg maintenance dose. By comparison, the injectable pen costs $349/month through NovoCare® Direct. With commercial insurance and the Savings Card, both formulations can cost as little as $25/month. The oral pill may be a more affordable option for cash-pay patients, particularly at the lower doses. [2]

Continue your research with these related articles from our Semaglutide Guide.

Ozempic Cost in 2026

Complete pricing breakdown for Ozempic with and without insurance, including copay cards and savings programs.

References

  1. Wegovy® (semaglutide) injection Prescribing Information. Novo Nordisk Inc.
  2. Wegovy® Cost & Coverage Information. Novo Nordisk.
  3. The Inflation Reduction Act and Medicare. Medicare.gov.
  4. NovoCare® Patient Assistance Program (PAP). Novo Nordisk.
  5. FDA Approves First Treatment to Reduce Risk of Heart Attack, Stroke in Adults with Obesity or Overweight. U.S. Food & Drug Administration.
  6. The Possible Dangers of Buying Medicines over the Internet. U.S. Food & Drug Administration.

Explore Your Options

Ready to take the next step? Compare Synedica’s precision wellness products or speak with our team about your weight management journey.

Explore Products Contact Our Team